The prospects and challenges of chimeric antigen receptor T cell therapy for head and neck squamous cell carcinoma

Int J Surg. 2023 Sep 1;109(9):2868-2871. doi: 10.1097/JS9.0000000000000527.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Cell- and Tissue-Based Therapy
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Receptors, Chimeric Antigen*
  • Squamous Cell Carcinoma of Head and Neck / therapy

Substances

  • Receptors, Chimeric Antigen